Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.
Candlestick & Bollinger Bands
News Feed
- Vinblastine Sulphate 1 mg/ml Injection - Summary of Product Characteristics (SmPC) by Hospira UK Ltd More
- AIA Engineering Ltd - Acquisition of 7,00,000 Equity Shares of Rs. 10 each of DCPL Foundries Private Ltd. More
- Tata Steel Ltd has informed BSE that the Company has filed the red herring prospectus dated January 11, 2011 (the “Red Herring Prospectus”) in respect to the Issue with the Registrar of Comp More
- KCR said he would soon visit the family members of Col Santosh Babu and present the cheque personally on behalf of the state government. More
- The investment in equity shares would be completed by March 31, 2020 through cash consideration More
©Copyright 2020
5Charts.com